Literature DB >> 19228479

Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis (the SEAS trial).

John A Farmer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19228479

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN： 1523-3804            Impact factor:   5.113


× No keyword cloud information.
  5 in total

Review 1.  LDL cholesterol goals in high-risk patients: how low do we go and how do we get there?

Authors:  Joost Besseling; Julian van Capelleveen; John J P Kastelein; G Kees Hovingh
Journal:  Drugs       Date:  2013-03       Impact factor: 9.546

Review 2.  Role of oxidative stress in calcific aortic valve disease and its therapeutic implications.

Authors:  Harry Z E Greenberg; Guoan Zhao; Ajay M Shah; Min Zhang
Journal:  Cardiovasc Res       Date:  2022-05-06       Impact factor: 13.081

Review 3.  The Haemodynamic and Pathophysiological Mechanisms of Calcific Aortic Valve Disease.

Authors:  Lydia Hanna; Chlöe Armour; Xiao Yun Xu; Richard Gibbs
Journal:  Biomedicines       Date:  2022-06-03

4.  Impact of Lowering Low-Density Lipoprotein Cholesterol with Contemporary Lipid-Lowering Medicines on Cognitive Function: A Systematic Review and Meta-Analysis.

Authors:  Hangying Ying; Jiacheng Wang; Zhida Shen; Meihui Wang; Binquan Zhou
Journal:  Cardiovasc Drugs Ther       Date:  2020-08-08       Impact factor: 3.727

Review 5.  Cholesterol metabolism and tumor.

Authors:  Ying Meng; Qifei Wang; Zhimin Lyu
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-02-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.